mercoledì 15 aprile 2009

Pelizaeus Merzbacher disease (PMD)









Findings

Figure 1: The coronal T2 image from age 5 demonstrates diffuse T2 hyperintensity in the cerebral white matter.
Figure 2, Figure 3, and Figure 4: Coronal T2 images from ages 8, 10, and 15 demonstrate gross stability of white matter signal abnormalities.
Figure 5 and Figure 6: Axial pre- and post- contrast images from age 15 demonstrate no abnormal enhancement in the white matter.


Diagnosis: Pelizaeus Merzbacher disease (PMD)


Pelizaeus-Merzbacher disease (PMD) is a rare leukodystrophy that is more properly categorized as a dysmyelinating disorder than a demyelinating disease. Demyelinating disorders such as adrenal leukodystrophy usually result from inborn errors in metabolism. Instead, PMD arises from a genetic defect affecting PLP-1, the primary protein in myelin.

The patient in this case was diagnosed with classic PMD which is the most common of the four forms of the disease. Classic PMD is an X-linked recessive disorder that results most frequently from the duplication of the PLP-1 gene. This genetic error causes a diffuse hypomyelination of the cerebral white matter.

Patients with classic PMD present in infancy with nystagmus, spasticity, and other motor problems. Because of this early presentation, cerebral palsy is the most common misdiagnosis for PMD patients as in this patient. As the patient becomes older, cognitive deficits are more conspicuous and further motor deficiencies may arise. The life span of patients with classic PMD is variable with many succumbing in adolescence and early adulthood while some other patients may live into the sixth decade.

The very slowly progressive MRI findings of classic PMD are quite specific for the disease especially when sequential exams are available for comparison. The cerebral white matter usually appears diffusely low in intensity on T1 images. Findings are more striking on T2 images where the hypomyelinated white matter remains diffusely hyperintense. The corpus callosum is notably atrophic. Myelination is usually present in the brainstem, thalamus, and posterior limbs of the internal capsules. Abnormal enhancement is not seen in PMD as opposed to some demyelinating disorders such as adrenal leukodystrophy in which enhancement is seen at the periphery of the active demyelination. In classic PMD, the MRI findings tend to be stable or mildly progressive over years since the primary problem is hypomyelination rather than demyelination.

1 commento: